The website provides detailed information about POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat), an FDA-approved two-component therapy for adults with Pompe disease. It serves as an educational and support platform targeting patients and healthcare providers, offering clinical trial results and resources. The site is built using modern web technologies including React and Gatsby, with a focus on accessibility and mobile responsiveness. Privacy and cookie policies are well implemented with consent mechanisms, reflecting good compliance practices. Security posture is solid with HTTPS enforced and domain protections in place, though DNSSEC is not enabled and explicit security policies are absent. Overall, the site is professional, trustworthy, and aligned with healthcare industry standards.
Scanned ·
NIS2 and GDPR posture
GDPR outside view
88/ 100 · Low
Checks completed
7of 7
NIS2 Art. 21(2)
a(a) Risk analysis and security policies: Not visible from outside
b(b) Incident handling: One indicator
c(c) Business continuity, backups and crisis management: Not visible from outside
d(d) Supply chain security: Not visible from outside
e(e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
f(f) Assessing the effectiveness of security measures: Not visible from outside
g(g) Cyber hygiene and security training: Not visible from outside
h(h) Cryptography and encryption: Partly checked
i(i) HR security, access control and asset management: One indicator
j(j) Multi-factor authentication and secured communications: Not visible from outside
Partly checked
One indicator
Not visible from outside
This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.
GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.
Priority findings
4 findings rated critical or high. Fix these first.
Email security
SPF, DKIM and DMARC stop others sending email that looks like it comes from your domain, a common route to phishing and invoice fraud.
Critical
No email authentication configured
Domain is vulnerable to email spoofing
What to do: Implement SPF, DKIM, and DMARC immediately
Security headers
Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.
High
Missing X-Frame-Options header
Prevents clickjacking attacks
What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"
This scan found 23 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.
Daily monitoring
Recommended
€25per month
TLS certificates and expiry
DNS records
SPF, DKIM and DMARC
Security headers
GDPR and NIS2 posture
Exposed services
Third-party trackers
Security score drift
Email alerts on material changes and an exportable JSON history of every change.
Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.
Results by check
Each check with its score, findings and the evidence it collected.
How this score is calculated
The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.
Counted in this score
SSL/TLS
62
Security headers
30
Email security
60
DNS health
75
Network security
100
GDPR outside view
88
Average
69
Not counted
NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.
Findings that cap the score at 49
Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.
The certificate is not trusted by browsers
The website is not served over HTTPS
A database, remote desktop, file-sharing or Telnet service is reachable from the internet
The page loads a script from a compromised source
The domain registration has expired
SPF authorises every server to send mail as the domain
Partial scans
When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.
Risk levels
Critical0–25
High26–49
Medium50–75
Low76–100
Breach exposure
Leaked credentials and lookalike domains from OffSeq Breach. The counts are free; the detailed lists are paid add-ons.
Dark web exposure
Add-on
Leaked records that mention pombilitiopfolda.com, from OffSeq Breach.
No leaked records found
Breach holds no records for pombilitiopfolda.com right now. New leaks arrive continuously, so monitoring on Breach alerts you if that changes.
Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.
Business context
Business profile
The business operates in the specialized healthcare sector, focusing on pharmaceutical therapy for a rare disease. The website acts as a product information and patient support channel rather than direct sales. Market positioning is niche with emphasis on FDA approval and clinical evidence. The business model revolves around education and support, likely complementing pharmaceutical distribution channels. No parent or subsidiary companies are identified. The site leverages partnerships with major analytics and advertising platforms for marketing and user engagement. Growth indicators include recent domain registration and comprehensive content targeting a specific patient demographic.
Security posture
Security maturity is moderate to good. The site uses HTTPS and domain status protections to prevent unauthorized changes. Cookie consent and accessibility scripts indicate attention to compliance and user experience. However, the absence of DNSSEC and explicit security policies or incident response contacts are gaps. No vulnerabilities or exposed sensitive data were detected in the analysis. Third-party scripts from major providers are used, which should be regularly audited. Overall, the site demonstrates a responsible security approach suitable for healthcare information dissemination but could improve transparency and DNS security.
Recommendations
Enable DNSSEC on the domain to enhance DNS security and prevent spoofing.
Publish a dedicated security policy and incident response contact information to improve transparency and trust.
Regularly audit and update third-party scripts to mitigate potential vulnerabilities.
Consider adding direct contact information such as verified company emails or phone numbers for better user support.
Implement and verify comprehensive security headers (CSP, X-Frame-Options, X-Content-Type-Options) to strengthen web security posture.
Site observations
Automated reading of the public site. Ratings are indicative.
Business
Company
Not explicitly stated
Description
Information about an FDA-approved two-component therapy option for certain adults, including how it works, trial results, and support resources.
Key services
Therapy education, Clinical trial information, Patient support and resources
Content quality
good
Branding
consistent
Technology
Stack
React, Gatsby, Tailwind CSS, Google Tag Manager, TikTok Pixel, OneTrust Cookie Consent, Accessibility Compliance Script (acsbapp)
Frameworks
React, Gatsby
Platforms
Squarespace Domains (Registrar), Google Cloud DNS
Performance
moderate
Mobile
good
Accessibility
good
SEO
good
Security
Observed score
80/100
Good practices seen
HTTPS enforced
ClientDeleteProhibited and ClientTransferProhibited domain status
Cookie consent banner implemented
Accessibility compliance script included
Analytics and tracking
Services
Google Analytics, TikTok Analytics, Facebook Analytics
Tracking level
moderate
Privacy practices
good
Advertising
Ad networks
Facebook Ads
Tracking pixels
TikTok Pixel, Facebook Pixel
Marketing tools
TikTok Analytics
Transparency
good
Site quality
Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high
Key observations
Website is a professionally designed healthcare product information site.
No signs of malicious or suspicious content.
Good use of modern web technologies and compliance tools.
No direct contact emails or phone numbers found; contact via form only.
Strong privacy and cookie policy presence with consent mechanisms.
No explicit security policy or incident response contacts published.
No vulnerability disclosure or security.txt found.
No suspicious external domains or links detected.
Technical notes
Notes
The website is built on a modern React and Gatsby framework with Tailwind CSS for styling, ensuring responsive and accessible design. It integrates multiple analytics and marketing tools including Google Tag Manager, TikTok Pixel, and Facebook Pixel, managed with a cookie consent mechanism. Hosting details are not explicit but DNS is managed via Google Cloud DNS and domain registered through Squarespace. Performance is moderate with good mobile optimization. The site lacks a traditional CMS, indicating a static or JAMstack approach. Technical debt appears low, but enabling DNSSEC and enhancing security headers would reduce risks. Overall, the infrastructure supports a professional and compliant healthcare information platform.
Standards and sources
Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.
Reviews of this site
Share your experience with pombilitiopfolda.com. Every review is verified by email and published after moderation.
Community rating
No published reviews yet. Be the first to review pombilitiopfolda.com.